From: Monkeypox epidemiology, clinical presentation, and transmission: a systematic review
May 7, 2022 | The first case in the UK, travel history from Nigeria |
---|---|
May 14, 2022 | The next two cases, both in the UK, are unrelated to the first |
May 19, 2022 | Canada becomes the second country to report 17 suspects. The government also announced that the first suspect was identified on April 29, 2022, with a travel history to the USA Italy also shares the date of becoming the second country to report the first confirmed case |
May 30, 2022 | Nigeria reported the death of a confirmed case (first) |
June 25, 2022 | WHO emergency committee opined that monkeypox was not a public health emergency (PHE) |
July 7, 2022 | WHO corrects itself and considers monkeypox as PHE |
July 8, 2022 | The demand for monkeypox vaccine outstrips the supply, and the USA government website to facilitate vaccination crashed on July 13, 2022 |
July 15, 2022 | CDC considered Tembexa, a drug used for smallpox for use despite multiple adverse effects The first case of monkeypox infection was confirmed in India |
July 19, 2022 | The infection was declared to be endemic in the MSM community |
July 23, 2022 | WHO recognized monkeypox as a Public Health Emergency of International Concern (PHEIC) |
August 1, 2022 | India reported the death of a confirmed case |
August 15, 2022 | A Spanish study suggested that the smallpox vaccine may not provide lifelong immunity from infection The first case of human-to-dog transmission was reported |
August 16, 2022 | Considering monkeypox as a misnomer, WHO opened the process of renaming the virus to the public |
August 26, 2022 | US doctors reported atypical or absolutely no symptoms in monkeypox infection |
September 9, 2022 | Neurological complications of monkeypox infection were reported |
September 16, 2022 | Caution against over-prescription of tecovirimat to prevent viral mutations |